IdentificationGeneric Name(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILEDrugBank Accession NumberDB08674BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE (DB08674)× CloseWeightAverage: 435.4772 Monoisotopic: 435.169524941 Chemical FormulaC26H21N5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaNot AvailableHumansUProtein farnesyltransferase subunit betaNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides.KingdomOrganic compoundsSuper ClassPhenylpropanoids and polyketidesClassMacrolactamsSub ClassNot AvailableDirect ParentMacrolactamsAlternative ParentsDiarylethers / Alpha amino acids and derivatives / Naphthalenes / Aralkylamines / Pyrrolidine-2-ones / N-substituted imidazoles / Tertiary carboxylic acid amides / Heteroaromatic compounds / Lactams / Oxacyclic compounds / Azacyclic compounds / Dialkylamines / Nitriles / Organopnictogen compounds / Organic oxides / Carbonyl compounds / Hydrocarbon derivatives


 show 7 moreSubstituents2-pyrrolidone / Alpha-amino acid or derivatives / Amine / Amino acid or derivatives / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenoid / Carbonitrile / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Diaryl ether / Ether / Heteroaromatic compound / Hydrocarbon derivative / Imidazole / Lactam / Macrolactam / N-substituted imidazole / Naphthalene / Nitrile / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Oxacycle / Pyrrolidine / Pyrrolidone / Secondary aliphatic amine / Secondary amine / Tertiary carboxylic acid amide


 show 26 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyUSPFJPDEADLGIG-HSZRJFAPSA-NInChIInChI=1S/C26H21N5O2/c27-12-19-5-4-17-10-25(19)33-21-7-6-18-2-1-3-24(22(18)11-21)31-9-8-23(26(31)32)29-14-20-13-28-16-30(20)15-17/h1-7,10-11,13,16,23,29H,8-9,14-15H2/t23-/m1/s1IUPAC Name(5R)-30-oxo-19-oxa-2,6,10,12-tetraazahexacyclo[18.6.2.1^{2,5}.1^{14,18}.0^{8,12}.0^{23,27}]triaconta-1(27),8,10,14(29),15,17,20(28),21,23,25-decaene-17-carbonitrileSMILES[H][C@@]12CCN(C1=O)C1=C3C=C(OC4=C(C=CC(CN5C=NC=C5CN2)=C4)C#N)C=CC3=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound23646577PubChem Substance99445145BindingDB14010ChEMBLCHEMBL496879ZINCZINC000003870365PDBe LigandU49PDB Entries1ld8Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.1 mg/mLALOGPSlogP2.51ALOGPSlogP2.53ChemaxonlogS-3.6ALOGPSpKa (Strongest Acidic)17.65ChemaxonpKa (Strongest Basic)6.56ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area83.18 Å2ChemaxonRotatable Bond Count0ChemaxonRefractivity124.12 m3·mol-1ChemaxonPolarizability44.65 Å3ChemaxonNumber of Rings6ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.9311Caco-2 permeable+0.5309P-glycoprotein substrateSubstrate0.5P-glycoprotein inhibitor INon-inhibitor0.6346P-glycoprotein inhibitor IINon-inhibitor0.6548Renal organic cation transporterInhibitor0.5088CYP450 2C9 substrateNon-substrate0.8042CYP450 2D6 substrateNon-substrate0.6477CYP450 3A4 substrateSubstrate0.5629CYP450 1A2 substrateInhibitor0.8519CYP450 2C9 inhibitorInhibitor0.6086CYP450 2D6 inhibitorNon-inhibitor0.5606CYP450 2C19 inhibitorInhibitor0.6215CYP450 3A4 inhibitorNon-inhibitor0.5833CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.8457Ames testAMES toxic0.589CarcinogenicityNon-carcinogens0.9081BiodegradationNot ready biodegradable0.9959Rat acute toxicity2.5284 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8296hERG inhibition (predictor II)Inhibitor0.5  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)1.67.530A31107IC 50 (nM)39007.522A31107


 Details


 Binding Properties1. Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionRab geranylgeranyltransferase activitySpecific FunctionEssential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. Contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl dipho...Gene NameFNTAUniprot IDP49354Uniprot NameProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaMolecular Weight44408.32 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. Protein farnesyltransferase subunit betaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionEssential subunit of the farnesyltransferase complex. Catalyzes the transfer of a farnesyl moiety from farnesyl diphosphate to a cysteine at the fourth position from the C-terminus of several prote...Gene NameFNTBUniprot IDP49356Uniprot NameProtein farnesyltransferase subunit betaMolecular Weight48773.2 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 